A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

Clinical trial NCT00347932 · COMPLETED

Trial details

NCT number: NCT00347932
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Bacterial Conjunctivitis

Start date: 2006-06-01
Primary completion: 2007-11-01
Enrollment: 957

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.